Perimeter

Perimeter Medical Imaging AI Shortlisted to Advance to Next Stage of Grant Funding Program Sponsored by the Advanced Research Projects Agency for Health (ARPA-H) under Biden Cancer Moonshot Initiative

Retrieved on: 
Thursday, October 5, 2023
OTC, PINK, OR, Cancer, Lymph, Blood, DARPA, Advanced Research Projects Agency for Health, FSE, PSI, Surgeon, MRI, ARPA, Perimeter, Patient, Medical imaging, Health

DALLAS and TORONTO, Oct. 5, 2023 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – announced that it has been shortlisted in a grant funding process sponsored by the Advanced Research Projects Agency for Health (ARPA-H) under its Precision Surgical Interventions (PSI) Program.

Key Points: 
  • DALLAS and TORONTO, Oct. 5, 2023 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – announced that it has been shortlisted in a grant funding process sponsored by the Advanced Research Projects Agency for Health (ARPA-H) under its Precision Surgical Interventions (PSI) Program.
  • Adrian Mendes, Perimeter's Chief Executive Officer stated, "We are excited to participate in this important Biden Cancer Moonshot initiative and thrilled that the federal Advanced Research Projects Agency for Health has selected Dallas as one of three regional hubs in its $2.5 billion health innovation network.
  • In alignment with the Biden Cancer Moonshot and to advance equity, the PSI program is designed to ensure emerging technologies that are accessible in rural and urban areas, improving health outcomes for all Americans facing cancer.
  • ARPA-H anticipates multiple awards and award types will result from program.

Verizon Announces Winners of the Second Climate Resilience Prize

Retrieved on: 
Wednesday, October 4, 2023
Climate, Partnership, Cohort, City, Perimeter, Creativity, Social innovation, Climate change, Aspen, Verizon Communications, Conference, Joel Makower, Renewable energy, Raincoat

BASKING RIDGE, N.J., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Today, Verizon announced the four winners of its second Climate Resilience Prize, an initiative enacted to help scale proven, in-market solutions that are focused on mitigating the disproportionate impacts of climate change on vulnerable communities, while awarding a total prize pool of $500,000, or $125,000 each.

Key Points: 
  • Verizon will continue to support winners in scaling their businesses through consulting and guidance in addition to awarding prize money.
  • BASKING RIDGE, N.J., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Today, Verizon announced the four winners of its second Climate Resilience Prize , an initiative enacted to help scale proven, in-market solutions that are focused on mitigating the disproportionate impacts of climate change on vulnerable communities, while awarding a total prize pool of $500,000, or $125,000 each.
  • The launch of the second Verizon Climate Resilience Prize was announced at the Aspen Ideas: Climate Conference in Miami, Florida in March 2023.
  • The Climate Resilience Prize, which launched in 2021, is part of Citizen Verizon, the company’s responsible business plan for economic, environmental, and social advancement.

Bradford Health Services Announces New Chief Executive Officer, Lisa Evans

Retrieved on: 
Tuesday, October 3, 2023
Professional Services, Health, Finance, Managed Care, Consulting, Banking, Independent Payment Advisory Board, Universal Health Services, Perimeter, Multimedia, HCA Healthcare, Health and Hospital Corporation of Marion County v. Talevski, Hospital, HCA, Corporation, SUD, Growth, UHS, Pharmaceutical industry, Management

Bradford Health Services, a leading substance use disorder (SUD) treatment provider in the Southeast, is pleased to announce the appointment of Lisa Evans as Chief Executive Officer.

Key Points: 
  • Bradford Health Services, a leading substance use disorder (SUD) treatment provider in the Southeast, is pleased to announce the appointment of Lisa Evans as Chief Executive Officer.
  • As a behavioral health industry veteran, Evans brings to Bradford over a decade of experience in leading growth and development initiatives across multi-state organizations.
  • Prior to joining Perimeter, Evans served in executive roles for national healthcare organizations, including Universal Health Services (UHS), Strategic Behavioral Health, and Hospital Corporation of America (HCA).
  • “I am extremely pleased to have Lisa as a partner to drive Bradford’s growth and development strategies,” said Jon O’Shaughnessy, Bradford Health Services Chairman of the Board.

Exploring F5G Evolution, Huawei Launches Three Enterprise Optical Network Solutions

Retrieved on: 
Friday, September 22, 2023
CONNECT, OTN, Education, Huawei, White paper, SDH, Perimeter, Intelligence, OSU, HUAWEI, APS, O&M, AI, WAN, Summit, Internet service provider

Richard Jin, President of Huawei Optical Business Product Line, said in his keynote speech, "Amid increasing application of AI, the industry poses new requirements on sensing and connectivity.

Key Points: 
  • Richard Jin, President of Huawei Optical Business Product Line, said in his keynote speech, "Amid increasing application of AI, the industry poses new requirements on sensing and connectivity.
  • Industry intelligence requires a sensing network and an all-optical network.
  • On top of that, we have launched a series of innovative F5G products and solutions to empower AI-enabled industries."
  • In the future, Huawei will continue to innovate based on F5G evolution, develop leading products and solutions, and work with customers and partners to facilitate intelligent upgrade of various industries.

Perimeter Medical Imaging AI Announces Issuance and Amendment of Options

Retrieved on: 
Wednesday, September 13, 2023
OTC, Perimeter, FSE, News, PINK, Consultant, Security (finance), DALLAS

TORONTO and DALLAS, Sept. 13, 2023 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – announced that, on September 13, 2023, it granted 3,523,408 stock options to certain directors, officers, consultants, and employees of the Company.

Key Points: 
  • TORONTO and DALLAS, Sept. 13, 2023 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – announced that, on September 13, 2023, it granted 3,523,408 stock options to certain directors, officers, consultants, and employees of the Company.
  • Of the 3,523,408 stock options issued, 3,195,908 stock options were issued to certain members of the executive team and directors.
  • The Company also announced that its board of directors has approved certain amendments to the vesting schedules of the Company options issued to certain employees of the Company in March 2023.
  • As previously announced, on March 23, 2023 the Company granted 1,510,000 stock options to certain directors, officers, consultants, and employees of the Company.

Perimeter Medical Imaging AI Strengthens Leadership Team with Appointment of Experienced MedTech Executive, Adam Hodges, as Vice President, Sales and Marketing

Retrieved on: 
Friday, September 8, 2023
Acceleration, Bachelor, Health, Integra, Perimeter, FSE, VAPO, Marketing, Business administration, Medtronic, Samford University, SIA, Lipscomb University, Person-centered therapy, OCT, OTC, Johnson & Johnson, Medtech, S series, Integra LifeSciences, NYSE, PINK, Accenture, Management, DALLAS, Vapotherm

TORONTO and DALLAS, Sept. 8, 2023 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – today announced the appointment of experienced medtech sales executive, Adam Hodges, as its Vice President, Sales and Marketing, effective immediately.

Key Points: 
  • TORONTO and DALLAS, Sept. 8, 2023 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – today announced the appointment of experienced medtech sales executive, Adam Hodges, as its Vice President, Sales and Marketing, effective immediately.
  • Adrian Mendes, Perimeter's Chief Executive Officer stated, "I am excited to welcome Adam to the Perimeter team as our senior leader responsible for the strategy and execution of our sales-related goals.
  • Adam Hodges brings more than 20 years of commercialization experience in the medical device industry.
  • Earlier in his career, Adam was an Executive Surgical Device Specialist for United States Surgical (Covidien/Medtronic) and a Sales Representative for Johnson & Johnson.

Perimeter Medical Imaging AI Announces Alignment with FDA on Key Elements of Ongoing Clinical Trial Evaluating AI-enabled B-Series OCT Medical Imaging Technology

Retrieved on: 
Thursday, September 7, 2023
Mayo Clinic, Surgeon, Dan, Classification, Breast surgery, Section, Clinical trial, Baylor University, Perimeter, FSE, Element, Patient, Clinical research, OTC, AI, FDA, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, PINK, Food, Pharmaceutical industry, Medical device, DALLAS

TORONTO and DALLAS, Sept. 7, 2023 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – today provided an update on the clinical development of its ongoing clinical trial evaluating the use of Perimeter B-Series OCT combined with its proprietary ImgAssist AI software during breast conservation surgery.

Key Points: 
  • TORONTO and DALLAS, Sept. 7, 2023 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – today provided an update on the clinical development of its ongoing clinical trial evaluating the use of Perimeter B-Series OCT combined with its proprietary ImgAssist AI software during breast conservation surgery.
  • Adrian Mendes, Perimeter's Chief Executive Officer stated, "This positive interaction with the FDA marks an important milestone in our clinical development program.
  • Perimeter received approval from the FDA to introduce an enhanced AI algorithm in the ongoing clinical trial under the existing study protocol.
  • As a result, all clinical trial sites will use the updated AI as patients continue to enroll in the ongoing study.

Perimeter Medical Imaging AI Reports Second Quarter 2023 Financial Results and Provides Corporate Update

Retrieved on: 
Tuesday, August 29, 2023
Mayo Clinic, Certified Management Accountant, Surgeon, CMA, Meta, University, International, International Accounting Standards Committee, Classification, Baylor College of Medicine, London Business School, Principal investigator, Clinical trial, Baylor University, Perimeter, Master, Sloan Fellows, FSE, Management science, ID, InterAction Council of Former Heads of State and Government, Baptists, Patient, International Financial Reporting Standards, Engineering, OCT, OTC, Webcast, CFO, Association of British HealthTech Industries, IAS, FDA, PINK, Medtech, International Accounting Standards Board, Management, Medical device, Cryptocurrency, DALLAS, Science

TORONTO and DALLAS, Aug. 29, 2023 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – today reported financial results for its second quarter ended June 30, 2023 and provided a corporate update.

Key Points: 
  • TORONTO and DALLAS, Aug. 29, 2023 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – today reported financial results for its second quarter ended June 30, 2023 and provided a corporate update.
  • In addition, I am pleased to report that Sara Brien will become Perimeter's Chief Financial Officer, effective September 1, 2023.
  • The study is evaluating the use of Perimeter B-Series OCT combined with its proprietary ImgAssist AI software during breast conservation surgery.
  • The Company will host a conference call and live audio webcast today, Tuesday, August 29, 2023, at 5:00 pm Eastern Time to discuss its second quarter 2023 results and to provide a corporate update.

Perimeter Medical Imaging AI Announces First Commercial Placement of Perimeter S-Series OCT in the State of Georgia

Retrieved on: 
Thursday, August 17, 2023
Optical coherence tomography, Candler Hospital (Savannah), Surgeon, OR, Cancer, Perimeter, FSE, DO, MRI, MD, Patient, OCT, OTC, FDA, PINK, Breast cancer, Medical imaging, DALLAS

TORONTO and DALLAS, Aug. 17, 2023 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – announced the first commercial placement of its flagship Perimeter S-Series OCT medical imaging system in the state of Georgia, which will be used at Candler Hospital, a part of St. Joseph's/Candler, in Savannah under the direction of breast surgeons, Catherine Ronaghan,  MD and Emma Walker, DO.

Key Points: 
  • TORONTO and DALLAS, Aug. 17, 2023 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – announced the first commercial placement of its flagship Perimeter S-Series OCT medical imaging system in the state of Georgia, which will be used at Candler Hospital, a part of St. Joseph's/Candler, in Savannah under the direction of breast surgeons, Catherine Ronaghan,  MD and Emma Walker, DO.
  • Perimeter S-Series OCT, which received FDA 510(k) clearance in 2021, is a medical imaging tool that uses Optical Coherence Tomography (OCT) to provide clinicians with cross-sectional, real-time margin visualization (1-2 mm below the surface) of an excised tissue specimen.
  • It provides 10 times higher image resolution than X-ray and ultrasound, and 100 times greater image resolution than MRI.
  • This latest commercial placement of our flagship Perimeter S-Series OCT, which marks the first in the state of Georgia, supports our goal to bring ultra-high resolution medical imaging technology directly into the OR to assist the surgeon with real-time intraoperative margin visualization."

Perimeter Medical Imaging AI Announces the Engagement of Bristol Capital Ltd. for Investor Relations Services

Retrieved on: 
Wednesday, August 16, 2023
Growth, CAD, Perimeter, FSE, News, Consultant, OTC, Security (finance), DALLAS, Bristol

TORONTO and DALLAS, Aug. 16, 2023 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – announced that it has retained Bristol Capital Ltd. ("Bristol") a leading investor relations firm servicing Canadian and US micro-cap and small-cap companies across international markets, to provide investor relations and communication services.

Key Points: 
  • TORONTO and DALLAS, Aug. 16, 2023 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – announced that it has retained Bristol Capital Ltd. ("Bristol") a leading investor relations firm servicing Canadian and US micro-cap and small-cap companies across international markets, to provide investor relations and communication services.
  • Adrian Mendes, Perimeter's Chief Executive Officer stated, "We are pleased to retain Bristol as part of our commitment to enhance our investor outreach efforts to engage with existing investors and grow our shareholder base.
  • Bristol will be paid a monthly fee of up to CAD$14,000, plus applicable taxes, based on the services to be provided during the applicable month, such fee payable by Perimeter within 30 days of receipt of invoice.
  • The appointment of Bristol remains subject to regulatory acceptance of applicable filings with the TSXV.